Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer

Background: Anti-programmed death 1 receptor (PD-1) therapy is a promising treatment strategy for patients with unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer. However, its response rate and survival benefits are still limited; an immunological analysis of the re...

Description complète

Détails bibliographiques

Auteurs principaux:	Hajime Matsuida, Kosaku Mimura, Shotaro Nakajima, Katsuharu Saito, Sohei Hayashishita, Chiaki Takiguchi, Azuma Nirei, Tomohiro Kikuchi, Hiroyuki Hanayama, Hirokazu Okayama, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Koji Kono
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-08-01
Collection:	Cells
Sujets:	anti-PD-1 therapy gastric/gastroesophageal cancer tumor resection tumor immune microenvironment HLA class I TGF-β
Accès en ligne:	https://www.mdpi.com/2073-4409/14/15/1212
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!